Suppr超能文献

永久性心脏起搏器植入治疗完全性心脏传导阻滞的年轻成人长期随访

Long-term follow-up of young adults following permanent pacemaker placement for complete heart block.

作者信息

Besley D C, McWilliams G J, Moodie D S, Castle L W

出版信息

Am Heart J. 1982 Mar;103(3):332-7. doi: 10.1016/0002-8703(82)90270-8.

Abstract

Young adults with nonsurgically induced complete heart block (CHB) do not necessarily have a benign prognosis and pacemaker (PM) implantation may be necessary. No one has reported long-term PM follow-up in young adults with CHB. We studied 13 patients aged 15 to 37 years (mean 24 years) at PM implantation. There were nine female and four male patients. All were functional class II or III (NYHA) before PM implantation. Syncope, dizziness, fatigue, shortness of breath, and dyspnea on exertion were the most common symptoms. Cardiac catheterization findings (11 of 13 patients) were normal in five, and additional cardiac anomalies were present in six. His bundle studies (9 of 13 patients) showed absent AH intervals in all patients, with HV intervals not identified in two, 20 to 30 msec in one, and 30 to 50 msec in six patients. Holter monitor recordings (8 of 13 patients) demonstrated CHB in all eight with intermittent second- to third-degree block in two of three patients. Two patients had occasional premature ventricular contractions. Stress exercise tests (9 of 13 patients) demonstrated increased ventricular rate response (although subnormal in some patients); symptoms developed in seven. One patient had ventricular ectopy. All 13 patients were contacted 3 months to 7 years (mean 4 years) after PM implantation. Two patients had died, but the deaths were not related to PM dysfunction. All patients who are currently alive had marked improvement in functional symptomatology and all are currently functional class I. CHB is not a benign condition in young adults and may require PM implantation, which improves symptoms and allows the patient to lead a normal life.

摘要

非手术诱发的完全性心脏传导阻滞(CHB)的年轻成年人不一定预后良好,可能需要植入起搏器(PM)。此前没有人报告过对患有CHB的年轻成年人进行起搏器的长期随访情况。我们研究了13例植入PM时年龄在15至37岁(平均24岁)的患者。其中有9名女性和4名男性患者。在植入PM之前,所有患者的心功能分级均为II级或III级(纽约心脏协会分级)。晕厥、头晕、疲劳、呼吸急促和劳力性呼吸困难是最常见的症状。心脏导管检查结果(13例患者中的11例)显示,5例正常,6例存在其他心脏异常。希氏束检查(13例患者中的9例)显示,所有患者均无AH间期,2例未测出HV间期,1例HV间期为20至30毫秒,6例为30至50毫秒。动态心电图监测记录(13例患者中的8例)显示,所有8例均为CHB,其中3例中有2例出现间歇性二度至三度阻滞。2例患者偶尔出现室性早搏。运动负荷试验(13例患者中的9例)显示心室率反应增加(尽管有些患者低于正常水平);7例出现症状。1例患者有室性异位搏动。在植入PM后3个月至7年(平均4年)对所有13例患者进行了随访。2例患者死亡,但死亡与PM功能障碍无关。所有目前存活的患者功能症状均有明显改善,目前心功能分级均为I级。CHB在年轻成年人中并非良性疾病,可能需要植入PM,这可改善症状并使患者能够过上正常生活。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验